Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy Type I [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase 1 clinical trial evaluated the safety and efficacy of EXG001-307 in patients with Spinal Muscular Atrophy Type I.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Muscular Atrophy

Drugs mentioned

• EXG001-307

Snippet

Sponsor: Guangzhou Jiayin Biotech Ltd | Conditions: Type I Spinal Muscular Atrophy | EARLY_Phase 1 | Status: COMPLETED